Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,271,137 papers from all fields of science
Search
Sign In
Create Free Account
AmpC beta-lactamases
Known as:
ampC beta-lactamase
, beta-lactamase ampC
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Bacterial Proteins
beta-Lactamase
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.
N. Alonso
,
E. Miró
,
+14 authors
P. Coll
International Journal of Antimicrobial Agents
2016
Corpus ID: 9435971
2016
2016
Low Occurrence of Extended‐Spectrum β‐lactamase‐Producing Escherichia coli in Finnish Food‐Producing Animals
M. Päivärinta
,
L. Pohjola
,
M. Fredriksson-Ahomaa
,
A. Heikinheimo
Zoonoses and Public Health
2016
Corpus ID: 13607883
ESBL/AmpC‐producing Escherichia coli is increasingly isolated from humans and animals worldwide. The occurrence of ESBL/AmpC…
Expand
Highly Cited
2015
Highly Cited
2015
Emission of ESBL/AmpC-producing Escherichia coli from pig fattening farms to surrounding areas.
C. von Salviati
,
H. Laube
,
B. Guerra
,
U. Roesler
,
A. Friese
Veterinary Microbiology
2015
Corpus ID: 8334414
2012
2012
Efficacy of chemical interventions against Escherichia coli O157:H7 and multidrug-resistant and antibiotic-susceptible Salmonella on inoculated beef trimmings.
I. Geornaras
,
Hua Yang
,
+6 authors
J. Sofos
Journal of Food Protection
2012
Corpus ID: 22979489
Studies were conducted to compare the decontamination efficacy of six chemical treatments against Escherichia coli O157:H7 and…
Expand
2009
2009
A Large Hospital Outbreak of Klebsiella pneumoniae (DHA-1 and SHV-11 Positive): Importance of Detection and Treatment of ampC β-Lactamases
T. Vanwynsberghe
,
K. Verhamme
,
+4 authors
H. Beenhouwer
2009
Corpus ID: 12972485
Plasmid-borne ampC � -lactamases are emerging worldwide. There is no gold standard in detecting them so it is presumed their…
Expand
2008
2008
Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.
M. Drissi
,
Z. Ahmed
,
B. Dehecq
,
R. Bakour
,
P. Plésiat
,
D. Hocquet
Médecine et maladies infectieuses
2008
Corpus ID: 32083444
1999
1999
Effects of interleukin‐10 and modulators of cyclic AMP formation on endotoxin‐induced inflammation in rat lung
N. Escofier
,
E. Boichot
,
N. Germain
,
P. M. Silva
,
M. Martins
,
V. Lagente
Fundamental & Clinical Pharmacology
1999
Corpus ID: 23722263
Abstract— The aim of this study was to investigate the effects of IL‐10, a cell permeable analogue of cyclic AMP, dibutyryl‐cAMP…
Expand
1987
1987
Synthesis and characterization of arylamine derivatives of rauwolscine as molecular probes for alpha 2-adrenergic receptors.
S. Lanier
,
R. Graham
,
+5 authors
C. Homcy
HYPERTENSION
1987
Corpus ID: 42433559
The selective alpha 2-adrenergic receptor antagonist rauwolscine was structurally modified to yield a series of arylamine…
Expand
1987
1987
Synthesis and Characterization of Arylamine Derivatives of Rauwolscine as Molecular Probes for α2‐Adrenergic Receptors
S. Lanier
,
R. Graham
,
+4 authors
C. Homcy
1987
Corpus ID: 12687100
The selective α2-adrenergic receptor antagonist rauwolscine was structurally modified to yield a series of arylamine carboxamide…
Expand
1986
1986
Photoaffinity labeling of the porcine brain alpha 2-adrenergic receptor using a radioiodinated arylazide derivative of rauwolscine: identification of the hormone-binding subunit.
S. Lanier
,
R. Graham
,
+5 authors
C. Homcy
Proceedings of the National Academy of Sciences…
1986
Corpus ID: 35597659
A functionalized derivative of the alpha 2-selective antagonist rauwolscine formed the basis for a photoaffinity adduct that has…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE